Raishay Lin is an associate in Ropes & Gray’s litigation & enforcement practice group. Her practice focuses on antitrust matters, including merger review advocacy and transaction risk counseling, particularly for health care clients. Raishay also has experience in complex civil litigation and government enforcement.
Raishay maintains an active pro bono practice. She has assisted in drafting amicus curiae briefs in three U.S. Supreme Court cases, as well as numerous briefs at the district court level to defend the Deferred Action for Childhood Arrivals (DACA) policy.
During law school, Raishay interned at the U.S. Attorney’s Office for the District of Maryland and in the Antitrust & Government Fraud department of the Office of the Connecticut Attorney General.
- Advising clients on advocacy and merger review processes before the DOJ, the FTC, and state regulators, including in several Second Requests.
- Representing clients facing antitrust and shareholder class action claims in trial and appellate courts.
- Counseling clients on antitrust compliance and best practices in potential mergers and acquisitions.
- Assisted Independent Compliance Monitor appointed by the DOJ and SEC pursuant to deferred prosecution agreement.
- Represented pharmaceutical client in successful appeal of an FDA administrative decision.
- Counseled pharmaceutical clients on changing regulations and active litigation regarding state drug price reporting laws.
- Co-author, “The New Class Action Frontier Under Illinois Privacy Law,” Law360 (January 16, 2020)
- Co-author, “The Future of Antitrust Claims at the ITC,” Law360 (May 15, 2018)
- JD, Harvard Law School, 2016; Managing Editor, Harvard Negotiation Law Review
- BA (English), magna cum laude, University of Maryland, 2013; University Medalist; Banneker-Key Scholar